![Anmol Wassan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anmol Wassan
Direttore operativo presso Biometry, Inc.
Profilo
Anmol Wassan is currently the Chief Operating Officer at Biometry, Inc. Prior to this, he worked as a Director of Professional Services at Virtify, Inc., and as a Principal at Merrill Lynch & Co., Inc. and Smith Barney & Co., Inc. He also has an undergraduate degree from Franklin & Marshall College, where he previously worked.
Posizioni attive di Anmol Wassan
Società | Posizione | Inizio |
---|---|---|
Biometry, Inc.
![]() Biometry, Inc. Packaged SoftwareTechnology Services Biometry, Inc. is a company that provides a platform called myBiometry to remotely monitor and manage patients with chronic conditions using software and biomarker data generated from proprietary sensors. Biometry is based in Boston, MA. The company's initial focus is on asthma, where they monitor changes in Fractional Exhaled Nitric Oxide (FeNO) to determine adherence, efficacy of medication, and risk of attack. The company was founded by Bryan Nolan, who has been the CEO since incorporation. | Direttore operativo | - |
Precedenti posizioni note di Anmol Wassan
Società | Posizione | Fine |
---|---|---|
Franklin & Marshall College | Corporate Officer/Principal | 21/01/2010 |
Smith Barney & Co., Inc. | Corporate Officer/Principal | - |
Merrill Lynch & Co., Inc. /Old/
![]() Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Corporate Officer/Principal | - |
Virtify, Inc.
![]() Virtify, Inc. BiotechnologyHealth Technology Virtify, Inc. provides life sciences solutions. It is engaged in the provision of enterprise content compliance solutions for the life sciences sector. The firm's products help users with managing labeling, disclosure, and documentation from pre-clinical through product registration to commercialization. The company was founded by Satish K. Tadikonda in 2004 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Virtify, Inc.
![]() Virtify, Inc. BiotechnologyHealth Technology Virtify, Inc. provides life sciences solutions. It is engaged in the provision of enterprise content compliance solutions for the life sciences sector. The firm's products help users with managing labeling, disclosure, and documentation from pre-clinical through product registration to commercialization. The company was founded by Satish K. Tadikonda in 2004 and is headquartered in Lexington, MA. | Health Technology |
Smith Barney & Co., Inc. | Finance |
Merrill Lynch & Co., Inc. /Old/
![]() Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
Biometry, Inc.
![]() Biometry, Inc. Packaged SoftwareTechnology Services Biometry, Inc. is a company that provides a platform called myBiometry to remotely monitor and manage patients with chronic conditions using software and biomarker data generated from proprietary sensors. Biometry is based in Boston, MA. The company's initial focus is on asthma, where they monitor changes in Fractional Exhaled Nitric Oxide (FeNO) to determine adherence, efficacy of medication, and risk of attack. The company was founded by Bryan Nolan, who has been the CEO since incorporation. | Technology Services |
- Borsa valori
- Insiders
- Anmol Wassan